A detailed history of Alliancebernstein L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 2,827,666 shares of BBIO stock, worth $74.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,827,666
Previous 2,452,404 15.3%
Holding current value
$74.9 Million
Previous $62.1 Million 15.89%
% of portfolio
0.03%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.91 - $31.3 $8.97 Million - $11.7 Million
375,262 Added 15.3%
2,827,666 $72 Million
Q2 2024

Aug 14, 2024

SELL
$23.0 - $31.04 $9.01 Million - $12.2 Million
-391,895 Reduced 13.78%
2,452,404 $62.1 Million
Q1 2024

May 14, 2024

BUY
$27.35 - $40.45 $7.85 Million - $11.6 Million
286,883 Added 11.22%
2,844,299 $87.9 Million
Q4 2023

Feb 14, 2024

SELL
$24.02 - $43.89 $3.81 Million - $6.97 Million
-158,724 Reduced 5.84%
2,557,416 $103 Million
Q3 2023

Nov 14, 2023

BUY
$16.89 - $35.01 $43.2 Million - $89.6 Million
2,560,549 Added 1645.69%
2,716,140 $71.6 Million
Q2 2023

Aug 15, 2023

BUY
$13.29 - $18.01 $303,450 - $411,222
22,833 Added 17.2%
155,591 $2.68 Million
Q1 2023

May 15, 2023

SELL
$7.17 - $18.55 $1,434 - $3,710
-200 Reduced 0.15%
132,758 $2.2 Million
Q3 2022

Nov 15, 2022

SELL
$7.94 - $12.36 $1.47 Million - $2.29 Million
-185,258 Reduced 58.22%
132,958 $1.32 Million
Q2 2022

Aug 15, 2022

SELL
$5.21 - $12.14 $200,668 - $467,584
-38,516 Reduced 10.8%
318,216 $2.89 Million
Q1 2022

May 13, 2022

SELL
$7.34 - $17.16 $441,853 - $1.03 Million
-60,198 Reduced 14.44%
356,732 $3.62 Million
Q4 2021

Feb 14, 2022

BUY
$11.38 - $53.41 $3.18 Million - $14.9 Million
279,232 Added 202.79%
416,930 $6.95 Million
Q3 2021

Nov 10, 2021

BUY
$46.87 - $64.24 $82,022 - $112,419
1,750 Added 1.29%
137,698 $6.45 Million
Q2 2021

Jul 30, 2021

SELL
$46.47 - $63.93 $111,992 - $154,071
-2,410 Reduced 1.74%
135,948 $8.29 Million
Q1 2021

May 06, 2021

BUY
$55.47 - $72.35 $1.91 Million - $2.49 Million
34,374 Added 33.06%
138,358 $8.52 Million
Q3 2020

Nov 12, 2020

SELL
$27.2 - $42.19 $66,177 - $102,648
-2,433 Reduced 2.29%
103,984 $3.9 Million
Q2 2020

Aug 13, 2020

BUY
$22.22 - $35.69 $151,096 - $242,691
6,800 Added 6.83%
106,417 $3.47 Million
Q1 2020

May 14, 2020

BUY
$16.11 - $36.23 $1.16 Million - $2.61 Million
72,164 Added 262.86%
99,617 $2.89 Million
Q4 2019

Feb 18, 2020

BUY
$17.96 - $46.63 $493,055 - $1.28 Million
27,453 New
27,453 $962,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.93B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.